5201 - 5210 of 8142 Results
Title
Year
-
RESTRICTEDTitle: Roles for the adaptive immune system in Parkinson’s and Alzheimer’s diseasesJournal Name: Current Opinion in ImmunologyPublisher: Elsevier BVVol: 59Issue #:Start Page: 115End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coi.2019.07.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774843Citation Count: 41
- Vesicular degradation pathways in neurons: at the crossroads of autophagy and endo-lysosomal degradation2019RESTRICTEDTitle: Vesicular degradation pathways in neurons: at the crossroads of autophagy and endo-lysosomal degradationJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.conb.2019.01.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629518Citation Count: 21
-
RESTRICTEDTitle: Young-onset Parkinson's disease: Its unique features and their impact on quality of lifeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 39End Page: 48Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.001Citation Count: 76
-
OPENTitle: Deep Learning With EEG Spectrograms in Rapid Eye Movement Behavior DisorderJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2019.00806Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2019.00806/pdfCitation Count: 92
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27806Citation Count: 101
- Phosphorylation of Ser111 in Rab8a Modulates Rabin8-Dependent Activation by Perturbation of Side Chain Interaction Networks2019OPENTitle: Phosphorylation of Ser111 in Rab8a Modulates Rabin8-Dependent Activation by Perturbation of Side Chain Interaction NetworksJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 33Start Page: 3546End Page: 3554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.9b00516Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2019/06/13/670729.full.pdfCitation Count: 9
-
RESTRICTEDTitle: Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 9Issue #: 3Start Page: 603End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191627Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191627?id=journal-of-parkinsons-disease%2Fjpd191627Citation Count: 82
- The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease2019OPENTitle: The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 9Issue #: 3Start Page: 553End Page: 563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191648Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191648?id=journal-of-parkinsons-disease%2Fjpd191648Citation Count: 35
-
RESTRICTEDTitle: CONTRIBUTORSJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 25Issue #: 4Start Page: 888End Page: 892Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000578728.22103.71Citation Count: 0
- Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls2019OPENTitle: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controlsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1392End Page: 1398Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27807Best OA location URL: https://europepmc.org/articles/pmc6754269?pdf=renderCitation Count: 26